Congress caps what patients pay for drugs—$2,000 a year, starting 2026
S. 529 — Capping Prescription Costs Act of 2025 · Filed by Raphael Warnock (D-GA) · 13 cosponsors · Introduced Feb 11, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill caps annual out-of-pocket costs for prescription drugs covered by health insurance plans at $2,000 per individual and $4,000 per family starting in 2026, with the cap adjusted annually for inflation. The cap applies to qualified health plans under the Affordable Care Act, group health plans, and self-insured employer plans.
Why we flagged it
The bill's operative mechanism is a direct, enforceable ceiling on patient out-of-pocket drug costs across all major insurance channels (ACA, group, self-insured). It is a consumer protection measure, not a market intervention or subsidy.
What the text implies
- The $2,000/$4,000 cap may shift cost burden upstream to insurers and pharmacy benefit managers, potentially increasing premiums or reducing drug formulary breadth if not offset by manufacturer pricing pressure or negotiation.
- The cap does not address drugs not covered by a plan; patients using non-formulary drugs remain exposed to full retail prices, creating a two-tier system.
- Inflation adjustment uses the medical care CPI component, which historically lags overall healthcare cost inflation, potentially eroding the cap's real value over decades.
- The bill does not specify enforcement mechanisms, penalties for non-compliance, or how disputes over cost-sharing calculations will be resolved.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Ordinary people with health insurance gain a concrete, enforceable limit on what they pay out-of-pocket for prescription drugs, reducing financial hardship from medication costs. The cap is indexed to inflation, protecting its value over time.
Who stands to gain
- patients with chronic conditions requiring expensive medications
- low-income and middle-income families with high drug costs
Named in the bill
Patient Protection and Affordable Care Act, Public Health Service Act, Employee Retirement Income Security Act, Internal Revenue Code, Bureau of Labor Statistics, health insurance issuers, group health plans, pharmacy benefit managers
Where it stands
13 cosponsors: 13 Democrats.
- Feb 11, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Feb 11, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (3,656 characters) on Aug 14, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress caps what patients pay for drugs—$2,000 a year, starting 2026” QuorumCivic. https://share.quorumcivic.app/bill/119/s529 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.